Publications

Journal Article
Meta-Analysis
Ppublish 212 citations
Electronic publication date
October 3, 2009

View on Pubmed.gov 19752408 | View on doi.org 10.1001/archint...

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Search for publications in this journal Arch Intern Med - 169(16):1500-6

Abstract

BACKGROUND

Numerous clinical trials have established a role for implantable cardioverter-defibrillators in the prevention of sudden cardiac death in patients with heart failure. However, questions remain that regard the clinical benefit of these therapies in different patient subgroups. Specifically, the role of implantable cardioverter-defibrillators in women with heart failure for the primary prevention of sudden cardiac death has not been well established. Our objective is to determine whether implantable cardioverter-defibrillators reduce mortality in women with advanced heart failure.

METHODS

We searched MEDLINE (1950-2008), EMBASE (1988-2008, week 24), the Cochrane Controlled Trials Register (third quarter, 2008), the National Institute of Health ClinicalTrials.gov database, the Food and Drug Administration Web site, and various reports presented at scientific meetings (1994-2007). Eligible studies were randomized controlled trials of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with heart failure that reported all-cause mortality as an outcome for the female population. Of the 2619 reports identified, 5 trials that enroll 934 women were included in the meta-analysis.

RESULTS

Pooled data from the 5 trials revealed no statistically significant decrease in all-cause mortality in women with heart failure who receive implantable cardioverter-defibrillators (hazard ratio, 1.01; 95% confidence interval, 0.76-1.33).

CONCLUSIONS

Implantable cardioverter-defibrillator therapy for the primary prevention of sudden cardiac death in women does not reduce all-cause mortality. Further studies are needed to investigate the reasons for this ob servation and to define the population of women who may benefit most from implantable cardioverter-defibrillator therapy.

References

No references provided.

Cited by 212 citations (total)

Journal Article Meta-Analysis Systematic Review

Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-Analysis.

Electronic publication date August 3, 2017

Search for publications in this journal PLoS One

David Conen [...] Tim Friede et al.

BACKGROUND

Some but not all prior studies have shown that women receiving a primary prophylactic implantable cardioverter defibrillator (ICD) have a...

Journal Article Review

Sex Differences in the Management of Advanced Heart Failure.

Electronic publication date September 23, 2018

Search for publications in this journal Curr Treat Options Cardiovasc Med

Daniela R Crousillat [...] Nasrien E Ibrahim et al.

PURPOSE OF REVIEW

Heart failure (HF) is prevalent among women and remains a leading cause of morbidity and mortality in the...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties